March 23 (Reuters) - Sigma Pharmaceuticals Ltd (SIP) :
- FY underlying npat up 13.0% to $66.9 million
- "we confirm our previous guidance of at least 5pct underlying ebit growth for fy18"
- FY revenue $4.4 billion, up 26.2pct
- Proposed final dividend of 3.0 cents per share